Auditory evoked potentials remain abnormal after CPAP treatment in patients with severe obstructive sleep apnoea

被引:15
|
作者
Vakulin, Andrew [1 ,2 ]
Catcheside, Peter G. [1 ,2 ,5 ]
Baulk, Stuart D. [3 ]
Antic, Nick A. [1 ,5 ]
van den Heuvel, Cameron J. [6 ]
Banks, Siobhan [4 ]
McEvoy, R. Doug [1 ,2 ,5 ]
机构
[1] Repatriat Gen Hosp, Adelaide Inst Sleep Hlth, Adelaide, SA 5041, Australia
[2] Univ Adelaide, Sch Med Sci, Discipline Physiol, Adelaide, SA 5005, Australia
[3] Integrated Safety Support, Adelaide, SA 5071, Australia
[4] Univ S Australia, Ctr Sleep Res, Adelaide, SA 5000, Australia
[5] Flinders Univ S Australia, Dept Med, Bedford Pk, SA 5041, Australia
[6] Univ Adelaide, Womens & Childrens Hosp, Childrens Res Ctr, Adelaide, SA 5006, Australia
基金
英国医学研究理事会;
关键词
Obstructive sleep apnoea; ERP; CPAP; EVENT-RELATED POTENTIALS; SIMULATED DRIVING PERFORMANCE; POSITIVE AIRWAY PRESSURE; DAYTIME SLEEPINESS; BREATHING DISORDERS; BRAIN-DYSFUNCTION; P300; LATENCIES; DEPRIVATION; ADULTS; WAKEFULNESS;
D O I
10.1016/j.clinph.2011.07.004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To assess the effects of 3 months of optimal CPAP treatment on auditory event related potentials (AERP) in patients with severe obstructive sleep apnoea (OSA) compared with healthy controls. Methods: Auditory odd-ball related N1, P2, N2 and P3 AERP components were assessed in 9 severe OSA subjects and 9 healthy controls at baseline evaluation and at similar to 3 months follow-up in both groups, with OSA subjects treated with continuous positive air-way pressure (CPAP) during this period. Results: Severe OSA subjects showed significantly delayed, P2, N2 and P3 latencies, and significantly different P2 and P3 amplitudes compared to controls at baseline (group effect, all p < 0.05). At follow-up evaluation P3 latency shortened in treated OSA patients but remained prolonged compared to controls (group by treatment interaction, p < 0.05) despite high CPAP compliance (6 h/night). The earlier AERP (P2 and N2) components did not change in either controls or OSA patients at follow-up and remained different in patients versus controls. Conclusions: This study demonstrates that in severe OSA patients AERP responses show minimal or no improvement and remain abnormal following 3 months of optimal CPAP treatment. Significance: Persistent cortical sensory processing abnormalities despite treatment in severe OSA may have implications for daytime neurobehavioral performance and safety in OSA patients. AERP responses may help identify residual performance deficits and risks. (C) 2011 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:310 / 317
页数:8
相关论文
共 50 条
  • [41] Cardiovascular outcomes in obstructive sleep apnoea and implications of clinical phenotyping on effect of CPAP treatment
    Xu, Pei-Hang
    Fong, Daniel Y. T.
    Lui, Macy M. S.
    Lam, David C. L.
    Ip, Mary Sau Man
    THORAX, 2023, 78 (01) : 76 - 84
  • [42] Comparative effects of CPAP and mandibular advancement splint therapy on blood pressure variability in moderate to severe obstructive sleep apnoea
    Dissanayake, Hasthi U.
    Sutherland, Kate
    Phillips, Craig L.
    Grunstein, Ronald R.
    Mihailidou, Anastasia S.
    Cistulli, Peter A.
    SLEEP MEDICINE, 2021, 80 : 294 - 300
  • [43] Autoadjusting-CPAP effect on serum Leptin concentrations in Obstructive Sleep Apnoea patients
    Drummond M.
    Winck J.C.
    Guimarães J.T.
    Santos A.C.
    Almeida J.
    Marques J.A.
    BMC Pulmonary Medicine, 8 (1)
  • [44] Effects of CPAP therapy on visceral fat thickness, carotid intima-media thickness and adipokines in patients with obstructive sleep apnoea
    Ng, Susanna S. S.
    Liu, Eric K. H.
    Ma, Ronald C. W.
    Chan, Tat-On
    To, Kin-Wang
    Chan, Ken K. P.
    Ngai, Jenny
    Yip, Wing-Ho
    Ko, Fanny W. S.
    Wong, Chun-Kwok
    Hui, David S. C.
    RESPIROLOGY, 2017, 22 (04) : 786 - 792
  • [45] An evaluation of the change in serum SCUBE-1 levels with CPAP treatment in patients with severe obstructive sleep apnea
    Ilden, Oguzhan
    Selcuk, Omer Tarik
    Ellidag, Hamit Yasar
    Selcuk, Nursel Turkoglu
    Eyigor, Hulya
    Renda, Levent
    Isik, Unal Gokalp
    Unlu, Hande Konsuk
    Osma, Ustun
    Eren, Esin
    Yilmaz, Necat
    CRANIO-THE JOURNAL OF CRANIOMANDIBULAR & SLEEP PRACTICE, 2022,
  • [46] An fMRI study of cerebrovascular reactivity and perfusion in obstructive sleep apnea patients before and after CPAP treatment
    Prilipko, Olga
    Huynh, Nelly
    Thomason, Moriah E.
    Kushida, Clete A.
    Guilleminault, Christian
    SLEEP MEDICINE, 2014, 15 (08) : 892 - 898
  • [47] Reduction in fall risk markers following CPAP treatment of obstructive sleep apnoea in people over 65 years
    Stevens, David
    Barr, Chris
    Bassett, Katherine
    Oh, Aaron
    Lord, Stephen R.
    Crotty, Maria
    Bickley, Kelsey
    Mukherjee, Sutapa
    Vakulin, Andrew
    SLEEP MEDICINE, 2022, 100 : 448 - 453
  • [48] Assessment of obstructive sleep apnoea treatment success or failure after maxillomandibular advancement
    de Ruiter, M. H. T.
    Apperloo, R. C.
    Milstein, D. M. J.
    de lange, J.
    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2017, 46 (11) : 1357 - 1362
  • [49] Obstructive Sleep Apnoea Syndrome, Endothelial Function and Markers of Endothelialization. Changes after CPAP
    Munoz-Hernandez, Rocio
    Vallejo-Vaz, Antonio J.
    Sanchez Armengol, Angeles
    Moreno-Luna, Rafael
    Caballero-Eraso, Candela
    Macher, Hada C.
    Villar, Jose
    Merino, Ana M.
    Castell, Javier
    Capote, Francisco
    Stiefel, Pablo
    PLOS ONE, 2015, 10 (03):
  • [50] CPAP treatment in obstructive sleep apnoea: A randomised, controlled trial of follow-up with a focus on patient satisfaction
    Holmdahl, C.
    Schollin, I-L
    Alton, M.
    Nilsson, K.
    SLEEP MEDICINE, 2009, 10 (08) : 869 - 874